Gunung Raja Paksi Tbk. vs Indofarma Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp330 (market cap 4.02T, 1.49M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Gunung Raja Paksi Tbk. is far larger — about 10.3× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| GGRP | INAF | |
|---|---|---|
Market Cap | 4.02T | 390.51B |
Volume | 1.49M | — |
Lot | 14.87K | — |
Turnover | 488.12M | — |
Average Price | 328.37 | — |
Value | 488.12M | — |
Indicative Equilibrium Price | 330 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →